Proteomics and Physiological Parameters Predicting Complications After Colorectal Cancer Surgery

Study combines physiological data from wearables, continuous glucose montiors and proteomics to better assess risk of complications after colorectal surgery

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Observation Postoperative

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Scheduled for elective colorectal cancer surgery

Exclusion criteria

Treatment and study plan

Risk stratification with proteomics and data from wearables and CGMs

Diagnostic Test

Risk Stratification

Primary outcomes

Complications (Clavien-Dindo >0)

Time frame: 30 days postoperatively

Secondary outcomes

Serious complications

Time frame: 30 days postoperatively

Clavien-Dindo>2

Study contacts

Contact information is provided by the study sponsor or research team.

Tomas Vedin, MD, PhD

CONTACT

[email protected]

+4640331200

Sponsors and collaborators

Lead sponsor

Region Skane

Other

Collaborators

Scilife Lab

Registry information

Official study title

Towards Precision Perioperative Medicine: Multimodal Prediction of Surgical Complications Using Proteomics and Physiological Monitoring

Acronym: ProComp

Important dates

Study start: 2026
Primary completion: 2028
Study completion: 2028
First posted: Mar 27, 2026
Registry last updated: Mar 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting